Fogarty International Training Program
The Fogarty International Research Training Program in Substance Abuse is a multi-center effort to increase the cadre of independent and collaborative researchers working in Poland, Slovakia, Latvia and the Ukraine and to improve the substance abuse research infrastructure in Central and Eastern Europe. The program, initiated by the University of Michigan and funded by the NIH Fogarty International Center and the National Institute on Drug Abuse, is a three-tiered program carried out in collaboration with the Institute of Psychiatry and Neurology (IPIN) in Warsaw, 
Poland. The program involves a partnership with institutions in Slovakia (the Institute and Centre for Treatment of Drug Dependencies in Bratislava), Ukraine (the Clinical and Social Narcology Department at the Ukrainian Research Institute of Social, Forensic Psychiatry, and Drug Abuse (URISFPDA) in Kiev and the Department for Prevention and Treatment of Drug Addictions at the Kharkov Institute of Neurology, Psychiatry, and Narcology of the Academy of Medical Sciences of the Ukraine, and Latvia (the Department of Psychiatry and Narcology at Riga Stradins University).
The first tier brings fellows to Ann Arbor for a year of mentored research training, followed by a second year of program-supported pilot research at the fellow’s home institution. The second tier involves a series of shorter term fellowships for mid-career and senior scientists to spend 1–3 months in the United States for focused training, protected writing time, and the development of collaborative relationships with American colleagues. The third tier, a yearly workshop series held in cities from each of the participating countries, is open to all levels of substance abuse scientists, from graduate students to more advanced and senior researchers. The curriculum involves short-term research training on specialized research issues, as well as sessions where attendees present their ongoing work.
The intent for all these activities is the development and extension of research programs for evaluation of existing treatment and prevention programming, conduct of new clinical trials in these areas, conduct of more basic research on etiology and clinical course and development of increased educational programming to sustain the learning that is initiated by training program exposure. A secondary goal, already accomplished successfully, is to foster research collaborations between program graduates and US scientists.
